Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, explains his research comparing hematopoietic stem cell transplantation (HSCT) with existing treatments in relapsing and progressive MS.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
